拓普药业 (837631.OC)

+ 收藏

利润表(拓普药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 35,771,870.3343,995,295.6229,242,638.1568,650,449.0649,828,313.90
 营业收入(元) 35,771,870.3343,995,295.6229,242,638.1568,650,449.0649,828,313.90
二、营业总成本(元) 35,089,721.3644,553,165.3027,843,852.4562,776,833.9143,810,391.23
 营业成本(元) 28,768,469.1032,198,934.2220,938,410.1750,637,355.3737,073,238.98
 研发费用(元) 1,279,782.054,059,489.232,072,561.933,144,445.952,034,431.07
 营业税金及附加(元) 760,239.70792,816.50721,795.49901,416.11842,362.17
 销售费用(元) 681,454.80584,563.79633,794.60499,772.59193,599.56
 管理费用(元) 3,347,172.716,394,462.413,121,953.366,916,803.843,278,955.59
 财务费用(元) 252,603.00522,899.15355,336.90677,040.05387,803.86
  其中:利息费用(元) 276,966.67579,308.32372,287.50687,919.80393,675.00
  其中:利息收入(元) 27,475.5560,018.6916,918.8816,982.019,268.62
三、其他经营收益
 加:投资收益(元) 20,803.9222,289.9422,289.9433,434.9133,434.91
 资产处置收益(元) ----65,563.98-
 资产减值损失(元) -198,293.38-469,546.76-277,804.57-
 信用减值损失(元) -176,106.27-582,353.31-398,820.54699,726.84-171,539.92
 其他收益(元) 985,838.922,566,119.701,300,950.013,916,063.29840,303.29
四、营业利润(元) 1,314,392.16978,639.892,323,205.1110,735,080.786,720,120.95
 加:营业外收入(元) 52,999.00255,495.562,731.00270,264.4314,809.48
 减:营业外支出(元) -22,782.453,000.0059,500.0024,500.00
五、利润总额(元) 1,367,391.161,211,353.002,322,936.1110,945,845.216,710,430.43
 减:所得税费用(元) --615,430.90178,751.941,145,374.72802,270.69
六、净利润(元) 1,367,391.161,826,783.902,144,184.179,800,470.495,908,159.74
(一)按经营持续性分类
  持续经营净利润(元) -1,826,783.902,144,184.179,800,470.495,908,159.74
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 1,367,391.161,826,783.902,144,184.179,800,470.495,908,159.74
 扣除非经常性损益后的净利润(元) 1,256,588.241,111,780.851,015,817.726,583,582.235,170,157.55
七、每股收益
 一、基本每股收益(元) 0.030.050.050.250.15
 二、稀释每股收益(元) 0.030.050.050.250.15
九、综合收益总额(元) -1,826,783.90-9,800,470.49-
 归属于母公司所有者的综合收益总额(元) 1,367,391.161,826,783.902,144,184.179,800,470.495,908,159.74
公告日期 2024-08-262024-04-262023-08-212023-04-262022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院